Nabriva
Therapeutics PLC -- ADR (NASDAQ: NBRV) announced, following the receipt of the final minutes of a Type A meeting it had with the FDA, it expects to resubmit the NDA for Contepo injection for treating complicated urinary tract infections, including acute pyelonephritis, early in the fourth quarter of 2019.
A new business intelligence report released by HTF MI with title "Global Mantle Cell Lymphoma
Therapeutics Market Size, Status and Forecast 2019-2025" has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy.
Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=930 Diverticular Disease
Therapeutics Market: Drivers and Restraints The growing prevalence and recurrence of diverticular disease is expected to be the major factor driving the growth of the diverticular disease
therapeutics market over the forecast period.
Release date- 07082019 - Evox
Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome
therapeutics company, is pleased to announce that the Company has been granted three key patents by the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO).
Zambon, a multinational pharmaceutical company, has acquired Breath
Therapeutics, a biopharmaceutical company, from France-based Sofinnova Partners.
26 February 2019 - Philadelphia, US-based commercial gene therapy company Spark
Therapeutics (NASDAQ: ONCE) has entered into a definitive merger agreement for Swiss healthcare company Roche (SIX: RO) (OTCQX: RHHBY) to fully acquire Spark
Therapeutics at a total equity value of USD 4.8bn in an all-cash transaction, the company said
Global Banking News-October 16, 2018-HiFiBiO
Therapeutics closes acquisition of H-Immune
TherapeuticsFate
Therapeutics has entered into a collaboration with ONO Pharmaceutical Co., Ltd.
London, United Kingdom, September 26, 2018 --(PR.com)-- SMi Group announces the 10th Annual RNA
Therapeutics Conference in London on February 20th - 21st 2019.
DUBLIN--Endo International PLC announced last month that it has reached terms to acquire New Jersey-based specialty pharmaceutical company Somerset
Therapeutics and the business of its India-based affiliate Wintac Ltd., which operates as Somerset
Therapeutics' contract developer and manufacturer.
NORDIC BUSINESS REPORT-April 12, 2018-Wilson
Therapeutics reports on unanimous recommendation by independent committee of the board of directors to public offer from Alexion Pharmaceuticals